Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obesity

Free Subscription Articles published in Eur J Endocrinol Retrieve available abstracts of 57 articles: HTML format

Single Articles

March 2024
1. VAN BEIJSTERVELDT IALP, van Zelst BD, Dorrepaal DJ, van den Berg SAA, et al
   Early life poly- and perfluoroalkyl substances (PFAS) levels and adiposity in the first 2 years of life.
   Eur J Endocrinol. 2024 Mar 30:lvae039. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. GATTA-CHERIFI B, Mohammedi K, Cariou T, Poitou C, et al
   Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
   Eur J Endocrinol. 2024 Mar 7:lvae024. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2024
3. FERNANDEZ-GARCIA P, Taxeras SD, Reyes-Farias M, Gonzalez L, et al
   Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.
   Eur J Endocrinol. 2024 Feb 20:lvae018. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2023
4. LEE J, Jung JH, Kim J, Jeong C, et al
   Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study.
   Eur J Endocrinol. 2023;189:527-536.
   PubMed     Abstract available
   
   
   October 2023
5. GATTA-CHERIFI B, Laboye A, Gronnier C, Monsaingeon-Henry M, et al
   A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.
   Eur J Endocrinol. 2023;189:K15-K18.
   PubMed     Abstract available
   
   
   
6. PLUIMAKERS VG, van Atteveld JE, de Winter DTC, Bolier M, et al
   Prevalence, risk factors and optimal way to determine overweight, obesity and morbid obesity, in the first Dutch cohort of 2,338 long-term survivors of childhood cancer: a DCCSS-LATER study.
   Eur J Endocrinol. 2023 Oct 14:lvad139. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2023
7. JONES TH, Dobs AS, Randeva H, Moore W, et al
   Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind Randomised Controlled Trial.
   Eur J Endocrinol. 2023 Aug 14:lvad099. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. INDER WJ, Grossmann M
   Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".
   Eur J Endocrinol. 2023 Aug 7:lvad100. doi: 10.1093.
   PubMed    
   
   
   July 2023
9. TRUEBA-TIMMERMANS DJ, Grootjen LN, Juriaans AF, Mahabier EF, et al
   Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
   Eur J Endocrinol. 2023;189:132-139.
   PubMed     Abstract available
   
   
   
10. OLLILA MM, Hoek A, Piltonen TT
    The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens.
    Eur J Endocrinol. 2023;189:R4-R5.
    PubMed    
    
    
    
11. SIMCHONI M, Derazne E, Pinhas-Hamiel O, Cukierman-Yaffe T, et al
    Adolescent body mass index and cognitive performance: a nationwide study of 2.48 million Israeli adolescents.
    Eur J Endocrinol. 2023;188:630-640.
    PubMed     Abstract available
    
    
    June 2023
12. EZQUERRO S, Tuero C, Becerril S, Valenti V, et al
    Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated NAFLD.
    Eur J Endocrinol. 2023 Jun 26:lvad071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. DWIVEDI AK, Vishwakarma D, Dubey P, Reddy S, et al
    Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
    Eur J Endocrinol. 2023;188:555-563.
    PubMed     Abstract available
    
    
    April 2023
14. CANNARELLA R, Caruso M, Condorelli RA, Timpanaro TA, et al
    Testicular volume in 268 children and adolescents followed-up for childhood obesity-a retrospective cross-sectional study.
    Eur J Endocrinol. 2023;188:331-342.
    PubMed     Abstract available
    
    
    March 2023
15. SONNEFELD L, Rohmann N, Geisler C, Laudes M, et al
    Is human obesity an inflammatory disease of the hypothalamus?
    Eur J Endocrinol. 2023 Mar 8:lvad030. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. BECKHAUS J, Friedrich C, Boekhoff S, Calaminus G, et al
    Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
    Eur J Endocrinol. 2023;188:lvad027.
    PubMed     Abstract available
    
    
    February 2023
17. GU P, Ding K, Lu L, Zhang Y, et al
    Compromised browning in white adipose tissue of ageing people.
    Eur J Endocrinol. 2023;188:lvad014.
    PubMed     Abstract available
    
    
    October 2022
18. PEKKARINEN L, Kantonen T, Rebelos E, Latva-Rasku A, et al
    Obesity risk is associated with brain glucose uptake and insulin resistance.
    Eur J Endocrinol. 2022 Oct 1. pii: EJE-22-0509. doi: 10.1530/EJE-22-0509.
    PubMed     Abstract available
    
    
    September 2022
19. VILACA T, Evans A, Gossiel F, Paggiosi M, et al
    Fat, adipokines, bone structure and bone regulatory factors associations in obesity.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0530. doi: 10.1530/EJE-22-0530.
    PubMed     Abstract available
    
    
    June 2022
20. ROSEN CJ
    3E: My Quarter Century Quest to Understand the Paradox of Marrow Adiposity.
    Eur J Endocrinol. 2022 Jun 1. pii: EJE-22-0499. doi: 10.1530/EJE-22-0499.
    PubMed     Abstract available
    
    
    May 2022
21. BLAGOJEVIC C, Heung T, Malecki S, Ying S, et al
    Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.
    Eur J Endocrinol. 2022;187:91-99.
    PubMed     Abstract available
    
    
    April 2022
22. MATHIESEN DS, Lund A, Holst JJ, Knop FK, et al
    THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
    Eur J Endocrinol. 2022;186:R93-R111.
    PubMed     Abstract available
    
    
    
23. GOEDEGEBUURE WJ, van der Steen M, Smeets CCJ, Kerkhof GF, et al
    SGA-born adults with postnatal catch-up have a persistently unfavorable metabolic health profile and increased adiposity at age 32 years.
    Eur J Endocrinol. 2022 Apr 1. pii: EJE-21-1130. doi: 10.1530/EJE-21-1130.
    PubMed     Abstract available
    
    
    March 2022
24. HUYNH K, Klose M, Krogsgaard K, Drejer J, et al
    Randomized Controlled Trial of Tesomet for Weight Loss in Hypothalamic Obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0972. doi: 10.1530/EJE-21-0972.
    PubMed     Abstract available
    
    
    
25. RUIZ S, Vazquez F, Pellitero S, Puig Domingo M, et al
    Pituitary dysfunction in obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0899. doi: 10.1530/EJE-21-0899.
    PubMed     Abstract available
    
    
    
26. DICHTEL LE, Haines MS, Gerweck AV, Bollinger B, et al
    Impact of GH administration on skeletal endpoints in adults with overweight/obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1061. doi: 10.1530/EJE-21-1061.
    PubMed     Abstract available
    
    
    February 2022
27. KOH HE, van Vliet S, Cao C, Patterson BW, et al
    Effect of obstructive sleep apnea on glucose metabolism.
    Eur J Endocrinol. 2022;186:457-467.
    PubMed     Abstract available
    
    
    
28. LAUGESEN K, Sorensen HT, Jorgensen JOL, Petersen I, et al
    Prenatal exposure to glucocorticoids and the prevalence of overweight or obesity in childhood.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0846.R1. doi: 10.1530/EJE-21-0846.
    PubMed     Abstract available
    
    
    
29. DHINDSA S, Ghanim H, Jenkins T, Inge TH, et al
    High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.
    Eur J Endocrinol. 2022;186:319-327.
    PubMed     Abstract available
    
    
    
30. KUFE C, Micklesfield LK, Masemola M, Chikowore T, et al
    Increased Risk for Type 2 Diabetes in Relation to Adiposity in Middle-Aged Black South African Men compared to Women.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0527. doi: 10.1530/EJE-21-0527.
    PubMed     Abstract available
    
    
    January 2022
31. LOH NY, Humphreys E, Karpe F, Tomlinson JW, et al
    Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian Randomisation study.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-0703.R2. doi: 10.1530/EJE-21-0703.
    PubMed     Abstract available
    
    
    December 2021
32. SONG Z, Gao M, Lv J, Yu C, et al
    Metabolically healthy obesity, transition to unhealthy phenotypes and type 2 diabetes in 0.5 million Chinese adults: The China Kadoorie Biobank.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0743.R1. doi: 10.1530/EJE-21-0743.
    PubMed     Abstract available
    
    
    
33. MAN S, Gao Y, Lv J, Tong M, et al
    Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0802.R2. doi: 10.1530/EJE-21-0802.
    PubMed     Abstract available
    
    
    
34. MOHSENI-TAKALLOO S, Beigrezaei S, Yazdanpanah Z, Rajaie SH, et al
    Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0675.R1. doi: 10.1530/EJE-21-0675.
    PubMed     Abstract available
    
    
    November 2021
35. DIETZ DE LOOS A, Jiskoot G, Beerthuizen A, Busschbach J, et al
    Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Eur J Endocrinol. 2021;186:53-64.
    PubMed     Abstract available
    
    
    
36. RUSSELL N, Hoermann R, Cheung AS, Zajac JD, et al
    Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Eur J Endocrinol. 2021;186:9-23.
    PubMed     Abstract available
    
    
    
37. ZHANG J, Chen X, Liu W, Zhang C, et al
    Metabolic surgery improves the unbalanced proportion of peripheral blood myeloid dendritic cells and T lymphocytes in obese patients.
    Eur J Endocrinol. 2021;185:819-829.
    PubMed     Abstract available
    
    
    
38. MANGOLIM AS, Brito LAR, Nunes-Nogueira VDS
    Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0473.R1. doi: 10.1530/EJE-21-0473.
    PubMed     Abstract available
    
    
    
39. YANG R, Hu Y, Lee CH, Liu Y, et al
    PM20D1 Is a Circulating Biomarker Closely Associated with Obesity, Insulin resistance and Metabolic Syndrome.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0847.R1. doi: 10.1530/EJE-21-0847.
    PubMed     Abstract available
    
    
    October 2021
40. ROMERO-RUIZ A, Pineda B, Ovelleiro D, Perdices-Lopez C, et al
    Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Eur J Endocrinol. 2021;185:637-652.
    PubMed     Abstract available
    
    
    September 2021
41. ANDERSEN MR, Suppli MP, Bagger JI, Christensen MB, et al
    MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
    Eur J Endocrinol. 2021;185:R93-R101.
    PubMed     Abstract available
    
    
    August 2021
42. NOGUEIRAS R
    MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.
    Eur J Endocrinol. 2021;185:R75-R91.
    PubMed     Abstract available
    
    
    June 2021
43. LEITER A, Carroll E, De Alwis S, Brooks D, et al
    Metabolic disease and adverse events from immune checkpoint inhibitors.
    Eur J Endocrinol. 2021;184:857-865.
    PubMed     Abstract available
    
    
    May 2021
44. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    PubMed     Abstract available
    
    
    
45. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    PubMed     Abstract available
    
    
    
46. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    PubMed     Abstract available
    
    
    
47. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    PubMed     Abstract available
    
    
    
48. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    PubMed     Abstract available
    
    
    
49. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    PubMed     Abstract available
    
    
    April 2021
50. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    PubMed     Abstract available
    
    
    
51. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    PubMed     Abstract available
    
    
    
52. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    PubMed     Abstract available
    
    
    January 2021
53. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    PubMed     Abstract available
    
    
    December 2020
54. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available
    
    
    November 2020
55. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    PubMed     Abstract available
    
    
    
56. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    PubMed     Abstract available
    
    
    September 2020
57. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.